These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15780827)

  • 1. Nuclear receptors and their relevance to diseases related to lipid metabolism.
    Berkenstam A; Gustafsson JA
    Curr Opin Pharmacol; 2005 Apr; 5(2):171-6. PubMed ID: 15780827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease.
    Smith AG; Muscat GE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyroid hormones and lipid metabolism].
    Sasaki S; Kawai K; Honjo Y; Nakamura H
    Nihon Rinsho; 2006 Dec; 64(12):2323-9. PubMed ID: 17154100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of coumestrol on lipid and glucose metabolism as a farnesoid X receptor ligand.
    Takahashi M; Kanayama T; Yashiro T; Kondo H; Murase T; Hase T; Tokimitsu I; Nishikawa J; Sato R
    Biochem Biophys Res Commun; 2008 Aug; 372(3):395-9. PubMed ID: 18457666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review.
    Ricketts ML; Moore DD; Banz WJ; Mezei O; Shay NF
    J Nutr Biochem; 2005 Jun; 16(6):321-30. PubMed ID: 15936643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome.
    Huang TH; Kota BP; Razmovski V; Roufogalis BD
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):3-14. PubMed ID: 15667590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of metabolism by nuclear hormone receptors.
    Huang HJ; Schulman IG
    Prog Mol Biol Transl Sci; 2009; 87():1-51. PubMed ID: 20374700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digging deep into the pockets of orphan nuclear receptors: insights from structural studies.
    Benoit G; Malewicz M; Perlmann T
    Trends Cell Biol; 2004 Jul; 14(7):369-76. PubMed ID: 15246430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand specificity of nuclear hormone receptors: sifting through promiscuity.
    Noy N
    Biochemistry; 2007 Nov; 46(47):13461-7. PubMed ID: 17983246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S; Moschetta A
    FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PXR and CAR in energy metabolism.
    Wada T; Gao J; Xie W
    Trends Endocrinol Metab; 2009 Aug; 20(6):273-9. PubMed ID: 19595610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
    George J; Liddle C
    Mol Pharm; 2008; 5(1):49-59. PubMed ID: 18072723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression.
    Roth A; Looser R; Kaufmann M; Blättler SM; Rencurel F; Huang W; Moore DD; Meyer UA
    Mol Pharmacol; 2008 Apr; 73(4):1282-9. PubMed ID: 18187584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR: a metabolic regulator and cell protector.
    Wang YD; Chen WD; Moore DD; Huang W
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR: a promising target for the metabolic syndrome?
    Cariou B; Staels B
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
    Chinetti-Gbaguidi G; Fruchart JC; Staels B
    Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear hormone receptors, metabolism, and aging: what goes around comes around. Transcription factors link lipid metabolism and aging-related processes.
    Pardee K; Reinking J; Krause H
    Sci Aging Knowledge Environ; 2004 Nov; 2004(47):re8. PubMed ID: 15564562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear receptor drug discovery.
    Chen T
    Curr Opin Chem Biol; 2008 Aug; 12(4):418-26. PubMed ID: 18662801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptors and inflammation.
    Moraes LA; Piqueras L; Bishop-Bailey D
    Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ; Planavila A; van der Vusse GJ; van Bilsen M
    Acta Physiol (Oxf); 2007 Nov; 191(3):171-88. PubMed ID: 17935522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.